PCN74 - A BUDGET-IMPACT ANALYSIS OF ADJUVANT PERTUZUMAB AND TRASTUZUMAB IN EARLY HER2-POSITIVE BREAST CANCER

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.156
https://www.valueinhealthjournal.com/article/S1098-3015(18)33456-9/fulltext
Section Title :
Section Order : 925
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33456-9&doi=10.1016/j.jval.2018.09.156
HEOR Topics :
Tags :
Regions :